The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Alzheimer’s Disease: Epidemiology and Clinical Progression
Open accessAbstract
Alzheimer's disease (AD) is prevalent throughout the world and is the leading cause of dementia in older individuals (aged ≥ 65 years). To gain a deeper understanding of the recent literature on the epidemiology of AD and its progression, we conducted a review of the PubMed-indexed literature (2014-2021) in North America, Europe, and Asia. The worldwide toll of AD is evidenced by rising prevalence, incidence, and mortality due to AD-estimates which are low because of underdiagnosis of AD. Mild cognitive impairment (MCI) due to AD can ultimately progress to AD dementia; estimates of AD dementia etiology among patients with MCI range from 40% to 75% depending on the populations studied and whether the MCI diagnosis was made clinically or in combination with biomarkers. The risk of AD dementia increases with progression from normal cognition with no amyloid-beta (Aβ) accumulation to early neurodegeneration and subsequently to MCI. For patients with Aβ accumulation and neurodegeneration, lifetime risk of AD dementia has been estimated to be 41.9% among women and 33.6% among men. Data on progression from preclinical AD to MCI are sparse, but an analysis of progression across the three preclinical National Institute on Aging and Alzheimer's Association (NIA-AA) stages suggests that NIA-AA stage 3 (subtle cognitive decline with AD biomarker positivity) could be useful in combination with other tools for treatment decision-making. Factors shown to increase risk include lower Mini-Mental State Examination (MMSE) score, higher Alzheimer's Disease Assessment Scale (ADAS-cog) score, positive APOE4 status, white matter hyperintensities volume, entorhinal cortex atrophy, cerebrospinal fluid (CSF) total tau, CSF neurogranin levels, dependency in instrumental activities of daily living (IADL), and being female. Results suggest that use of biomarkers alongside neurocognitive tests will become an important part of clinical practice as new disease-modifying therapies are introduced.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The diseases encompass various severe conditions, including neurodegenerative disorders like Alzheimer’s disease (AD) [3, 4] and Parkinson’s disease (PD) [5, 6], as well as traumatic brain injuries (TBI) [7] and spinal cord injuries (SCI) [8].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Elsevier eBooks · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,168
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
Harada, C. N., Love, M. C. N., & Triebel, K. L. (2013) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2013.07.002 · Cited by 2,649
Nichols, E., Szoeke, C. E. I., Vollset, S. E., Abbasi, N., Abd-Allah, F., Abdela, J., Aichour, M. T. E., Akinyemi, R. O., Alahdab, F., Asgedom, S. W., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30403-4 · Cited by 2,412 · cited 2×
“4% of all deaths attributable to dementia in 2016 [31].”
Background
Cited by
Sorted by citations
Items 401–500 of 652
Kim, S.-S., Kim, W., Moon, H., Oh, S., Hong, G.-S., Lee, B., Choi, C. W., Lee, B., Choi, J. S., & Kim, M. S. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177645 · Cited by 1
Agarwal, U., Paliwal, S., Yadav, V., Pannu, A. S., Tonk, R. K., & Verma, S. K. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273402657250905055635 · Cited by 2
Small noncoding RNAs: Pioneering a new therapeutic era in Alzheimer’s disease
Sahoo, S., Pattanaik, S., Kar, D. M., Prusty, S. K., & Sahu, P. K. (2025) · Gene · doi:10.1016/j.gene.2025.149827 · Cited by 1
Christodoulou, R. C., Vamvouras, G., Sarquis, M. D., Petrou, V., Papageorgiou, P. S., Rivera, L., Morales, C., Rivera, G., Vassiliou, E. K., Solomou, E. E., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13112632 · Cited by 1
Alzheimer's disease and suicide association (ASA) theory
Rodrigues, J. F. R., & Filho, G. M. D. A. (2025) · New Ideas in Psychology · doi:10.1016/j.newideapsych.2025.101218 · Cited by 1
Alzarea, S. I. (2025) · Scientific Reports · doi:10.1038/s41598-025-22955-7 · Cited by 1
Drozdowska, D., Ratkiewicz, A., Wróbel, A., Parzych, C., El-Dershaby, H. A., Razik, H. A. A. E., Soliman, F. S. G., & El‐Wakil, M. H. (2025) · ACS Omega · doi:10.1021/acsomega.5c08737 · Cited by 1
Ursi, G. Z., da Silva, M. R., Nakakogue, L. M., Fernandes, K. B. P., & Bignardi, P. R. (2025) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000700 · Cited by 1
Aksöz, E., Karabulut, M., & Yaranoğlu, M. H. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115998 · Cited by 1
Moien, M. A. S., Saghravanian, S. J., & Fereidoni, M. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.12.012 · Cited by 1
Tripathi, S. M., Shiells, H., Waymont, J. M. J., Staff, R. T., Schelter, B. O., Bentham, P., Wischik, C. M., & Murray, A. D. (2026) · Current Alzheimer Research · doi:10.2174/0115672050399596251106033110 · Cited by 2
Blood-based biomarkers and early diagnosis of Alzheimer’s disease
Cui, Z., Li, G., Wei, S., Cheng, Q., Yu, Q., Zong, S., Zhang, P., Chen, H., Yu, S., Wu, S., et al. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00759 · Cited by 1
Alzheimer’s disease and exposome: is there really a connection? Literature review and meta-analysis
Zayani, C. B. H. Y., Abdelhédi, R., & Gargouri, I. (2026) · Euro-Mediterranean Journal for Environmental Integration · doi:10.1007/s41207-025-01023-6 · Cited by 1
Faeed, M., Hosseini, H., Abdollahi, A., Aziz, M., Darabi, H., Sohrabi-Ashlaghi, A., Farhadi, S., Nobari, M. N., & Badakhshan, H. (2026) · BMC Neurology · doi:10.1186/s12883-026-04758-z · Cited by 1
Ensemble-Based Estimation of Alzheimer’s Disease Incidence from Dynamic Population Reconstructions
Bertaglia, G., Iacomini, E., & Viguerie, A. (2026) · SIAM Journal on Life Sciences · doi:10.1137/25m1782522 · Cited by 1
Treccarichi, S., Papa, C., Vinci, M., Cosentino, F., Scalia, G., Mostile, G., Zappia, M., Nicoletti, A., Pennisi, M., Musumeci, A., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-47948-y · Cited by 2
Zhu, S., Li, Y., Lin, C., Liu, X., Luo, Y., Qian, H., & Tang, Z. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05225-9 · Cited by 1
Alkhuder, K. (2026) · Journal of Clinical and Translational Research · doi:10.36922/jctr025270035 · Cited by 1
Shin, S., Zhu, X., Amartumur, S., Lee, T. R., Yu, W. J., Park, S., Etemadi, N., Jamsranjav, A., Kang, R., Bak, G., et al. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01684-5 · Cited by 1
Xu, R., Ma, X., Wu, L., Yin, D., Zhao, L., Zhou, M., Yao, Y., Lin, R., Li, W., & Yu, K. (2026) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2026.03.007 · Cited by 1
Nazli, D., Poyraz, Y. K., Can, K., Ipekgil, D., Cakmak, N., Turhanlar‐Sahin, E., Hacoglu, S., Erdost, H. A., Iyilikci, L., & Ozhan, G. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05906-9 · Cited by 1
Ma, Y., Ma, C., Yang, A., Chen, Y., Gao, J., Wang, Q., Wei, Z., Gao, M., Xing, X., & Liu, W. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02924-x · Cited by 1
Amruthavarshini, S. N., Kumari, N., & Anand, S. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06015-3 · Cited by 1
Yu, H., Abbasi, A. A., Khan, H., Hu, H., & Lu, P. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s606644 · Cited by 1
Kumar, N., Mir, P. A., Bhutia, G. T., Chaudhary, P., Kaur, G., Alam, Q., Pawar, S. D., & Gupta, S. K. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05983-w · Cited by 1
Unhealthy dietary patterns and Alzheimer’s disease: associations and underlying mechanistic pathways
Ramasinghe, C., & Xu, B. (2026) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2026.2691237 · Cited by 1
Pan, C., Ma, J., Yuan, X., Li, R., Zheng, X., Yan, J., Xie, Z., Liu, M., Xu, J., Su, Y. A. N. G. A. N., et al. (2026) · International Psychogeriatrics · doi:10.1016/j.inpsyc.2026.100234 · Cited by 1
Nassir, C. M. N. C. M., Vishnumukkala, T., Gopalakrishna, P. K., Jagadeesan, S., Nor, N. H. M., Mehat, M. Z., Moklas, M. A. M., Hein, Z. M., & Kamaruzzaman, M. A. (2026) · Biomedicines · doi:10.3390/biomedicines14071609 · Cited by 2
Herpes simplex virus infection and Alzheimer’s disease
Hur, J. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1858017 · Cited by 1
Huang, Y. Q., Wong, E. K. C., Straus, S. E., Lane, N. E., Bier, N., Isaranuwatchai, W., & Watt, J. A. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-08177-0 · Cited by 1
Zhao, G., Zhao, S., & Xie, X. (2023) · Springer eBooks · doi:10.1007/978-981-99-1284-1_32 · Cited by 1
Dilek, F., & Ünal, A. (2023) · Balkan Sağlık Bilimleri Dergisi · doi:10.61830/balkansbd.1364344 · Cited by 1
Volumetric Analysis of Choroid Plexus for the Early Detection of Alzheimer's Disease
Sathish, D., & Kabekody, S. (2024) · International Conference on Software and Computer Applications (ICSCA) · doi:10.1145/3651781.3651807 · Cited by 1
Pallathadka, H., Gardanova, Z. R., Al-Tameemi, A. R., Al‐Dhalimy, A. M. B., Kadhum, E. H., & Redhee, A. H. (2024) · Iranian Journal of Psychiatry · doi:10.18502/ijps.v19i3.15808 · Cited by 1
Li, R., Chen, W., Zhang, H., Liang, Q., Wang, L., Peng, W., & Wu, C.-J. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250214 · Cited by 1
Kuck, M. J., Begde, A., Hawkins, K., & Hogervorst, E. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231415 · Cited by 1
Luengnaruemitchai, G., Sangchocanonta, S., Munthuli, A., Phienphanich, P., Puangarom, S., Jariyakosol, S., Hirunwiwatkul, P., & Tantibundhit, C. (2024) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc53108.2024.10782014 · Cited by 1
Iakunchykova, O. P., Schirmer, H., Roe, J. M., Sørensen, Ø., Wilsgaard, T., Hopstock, L. A., Eggen, A. E., Benros, M. E., Chen, C., & Wang, Y. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251317624 · Cited by 1
Bi, A., Lu, Z., & Ying, W. (2025) · Journal of Mechanics in Medicine and Biology · doi:10.1142/s0219519425400111 · Cited by 1
Xu, Y., Zhang, Z., Peng, J., Li, X., Xu, Y., Song, Q., Shu, Z., & Xie, Y. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.04.031 · Cited by 1
Shami, R., Majzoub, R. E., Ismail, A., Kotaich, J., Kassem, M., Safadieh, G., Fayyad‐Kazan, M., & Chahine, B. (2025) · Neurodegenerative Disease Management · doi:10.1080/17582024.2025.2562776 · Cited by 1
Reiss, A. B., & Pinkhasov, A. (2024) · Medicina · doi:10.3390/medicina60050712 · Cited by 1
Unraveling the Plausible Role of Potassium Channel Openers in Alzheimer's Disease
Kumar, S., Sharma, B., Sharma, A. R., & Sharma, N. (2024) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249330827240819040302 · Cited by 1
Causal links between mitophagy and Alzheimer’s disease: a Mendelian randomization studyPreprint
Zhang, W., Chen, W., Guo, Z., & Li, H. (2024) · medRxiv · doi:10.1101/2024.10.01.24314751 · Cited by 1
Wen, Y., Wang, S., Yu, C., & Yu, H. (2025) · Research Square · doi:10.21203/rs.3.rs-7812084/v1 · Cited by 1
Emen, A., & İlk, Ö. (2025) · doi:10.22541/au.176502433.39807870/v1 · Cited by 1
Miao, J., Wang, J., Li, Y., Zhang, H., Zhang, Y., Li, Q., Xiao, B., Zhou, W., & Guo, J. (2026) · Advanced Science · doi:10.1002/advs.77929
Identificación de circRNAs como biomarcadores epigenéticos candidatos en la enfermedad de Alzheimer
Urdánoz‐Casado, A. (2022) · Academica-e (Universidad Pública de Navarra) · doi:10.48035/tesis/2454/43427
Khaire, A. S., Wen, J., Yang, X., Zhou, H., Shen, Y., & Li, Y. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.01.514771
Understanding the Mechanisms of Amyloid Beta (Aβ) Aggregation by Computational Modeling
Rao, P. P. N., Zhao, Y., & Huang, R. (2023) · Neuromethods · doi:10.1007/978-1-0716-3311-3_2
Sherimon, V., Cherian, S. P., Nair, R. V., Shaikh, K. A., & Mathew, N. (2023) · Advances in computational intelligence and robotics book series · doi:10.4018/978-1-6684-6971-2.ch018
Wang, Y., Zhao, K., Duan, R., Qiu, S., & Initiative, A. D. N. (2023) · Research Square · doi:10.21203/rs.3.rs-3326324/v1
Mente e memória : uma exploração multidisciplinar da doença de Alzheimer.
Zanuto, B. S., Bosch, A. L., Kawaguti, B. B. N. R., Ramos, D. D. F. F., Nery, D. L., Rocha, H. S., de Pinho, L. A., Cortês, M. C., Lobo, N. S., & de Melo, V. M. S. (2023) · Brazilian Journal of Implantology and Health Sciences · doi:10.36557/2674-8169.2023v5n4p1695-1709
Recent Progresses in Neural Networks for Alzheimer's Disease DetectionPreprint
Zhao, M. (2023) · Preprints.org · doi:10.20944/preprints202310.0771.v1
Basic Experimental Model of Memory Impairment in Alzheimer’s Disease
胡, 祥. (2023) · Open Journal of Natural Science · doi:10.12677/ojns.2023.116110
Jaul, E., Factor, H., & Meiron, O. (2023) · Research Square · doi:10.21203/rs.3.rs-3573907/v1
Garea-Llano, E., Pino, S. L., & Martinez-Montes, E. (2023) · Lecture notes in computer science · doi:10.1007/978-3-031-49552-6_24
Sterol Biomarker Discovery In Neurodegenerative Diseases
Pacciarini, M. (2023) · Cronfa (Swansea University) · doi:10.23889/suthesis.65375
Alpua, M., Kısa, Ü., Tekin, E., & Ergün, U. (2024) · Journal of Medical and Health Studies · doi:10.32996/jmhs.2024.5.1.6
The Impact of Vitamin D on Alzheimer's Disease: A Mendelian Randomization StudyPreprint
pei, D., Wang, S., & Li, X. (2024) · Research Square · doi:10.21203/rs.3.rs-3974113/v1
Major Neurocognitive Disorders Due to Alzheimer’s Disease
Joshi, P., Patel, N., & Gopalakrishna, G. (2024) · Springer eBooks · doi:10.1007/978-3-031-55711-8_1
Pooja, R. C., & Bharathi, D. R. (2024) · Research Square · doi:10.21203/rs.3.rs-4531379/v1
Hamdellou, A., Addad, D., Derardja, I., Kadi, K., Elmastaş, M., Soy, M., Mısırlı, D., Lekmine, S., & Samira, K. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4866657
Gene-Based Management of Alzheimer’s Disease: Role of Coumarins of Ferulago Genus
Dabaghian, F., Niaraki, S. R. A. H., Azargashb, N., Aalinezhad, S., Sharifzadeh, M. S., Delnavazi, M., & Khanavi, M. (2024) · Sustainable landscape planning and natural resources management · doi:10.1007/978-3-031-60117-0_14
Sönmez, D., & Hocaoğlu, Ç. (2024) · Anadolu Kliniği Tıp Bilimleri Dergisi · doi:10.21673/anadoluklin.1476946
Samakkhiwitthayakhom, T. S. (2024) · International Journal of Current Science Research and Review · doi:10.47191/ijcsrr/v7-i7-97
Editorial: New strategies in neuroprotection and neurorepair
Huang, E., Liu, J., & Ai, W. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1461195
Alchalabi, T., & Lodhi, T. I. (2024) · Topics in Geriatric Care. · doi:10.1007/978-981-97-5995-8_7
The Role of the Skin Microbiome in Atopic Dermatitis
Subaihawi, A. J. K. A., Almohammedi, T. G., & Shabbani, N. H. S. A. (2024) · European Journal of Medical and Health Research · doi:10.59324/ejmhr.2024.2(5).38
Ren, J.-J., Ye, Y., Zhang, Y., Zhu, Y., Ge, P., Luo, Y., & Wang, J. H. (2024) · Medicine · doi:10.1097/md.0000000000040765
Bogolepova, A. N., Makhnovich, E. V., Коваленко, Е. А., Osinovskaya, N. A., & Beregov, M. M. (2024) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2024124121142
Understanding Alzheimer’s Disease: A Multidisciplinary Perspective
Akbarzadehmoallemkoalei, M., Yektakasmaei, M. P., Tabar, S. S. S., Zolfaghari, K., Noorikoloori, S., Niktalab, P., Rouzrokh, S., Sheykhzadeh, Z., Sanavi, M. A., Dozdouzan, M. A., et al. (2024) · Integrated science · doi:10.1007/978-3-031-72079-6_14
Sampatakakis, S. N., Mourtzi, N., Hatzimanolis, A., Koutsis, G., Charisis, S., Gkelmpesi, I., Mamalaki, E., Ntanasi, E., Ramı́rez, A., Yannakoulia, M., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030910
The proof is in the pudding: patient engagement in studying cannabidiol in mild cognitive impairment
Keck, A., Scheuermann, J.-S., Scheerbaum, P., Graessel, E., & Müller‐Vahl, K. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-04753-w
Ensemble Methods for Early Prediction of Dementia
Abirami, T., Jayadharshini, P., Prathiksha, S. V., Kangeyan, S. E. P., & Mohanram, M. B. (2024) · IEEE International Conference on ICT in Business Industry & Government (ICTBIG) · doi:10.1109/ictbig64922.2024.10911083
Modifiable risk factors of dementia in the Indian scenario
Ankul Singh, S., Chandran, L., & Vellapandian, C. (2025) · Future Science OA · doi:10.1080/20565623.2025.2483132
Jangwan, N. S., & Singh, M. F. (2025) · Indian Journal of Experimental Biology · doi:10.56042/ijeb.v63i04.14075
Zueva, I., Saifina, L. F., Gubaidullina, L. M., Shulaeva, M., Kharlamova, A., Lenina, O., Belyaev, G., Ziganshina, A., Gao, S., Tang, W.-J., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083759
Unraveling Alzheimer's: A holistic approach to diagnosis, stages and intervention
Dasari, R. D. R., Bhukya, G., Varadammagari, S. V. S., Gujjala, A. G. A., Mugannagari, P. M. P., Pasala, P. K., Reddy, K. S., & Vattikuti, U. M. R. (2025) · International Journal of Science and Research Archive · doi:10.30574/ijsra.2025.15.1.1078
Actualización en el diagnóstico y manejo del Alzheimer: revisión narrativa
Luna, D. S. V., Coloma-Ramirez, L., Jácome, P. N. T., Avellán, Á. B. C., Granda-Peñafiel, N., Abril, V. N. C., Palacios, J. A. I., & López, A. D. L. A. C. (2025) · Florence. · doi:10.56183/florence25003
Virtual Reality-Based Exposure Therapy System for Cognitive Rehabilitation in Alzheimer’s Disease
Chen, J., Qin, K., Yang, L., Zhang, S. Z., Lu, X., & Shu, L. (2025) · Lecture notes in computer science · doi:10.1007/978-3-031-92710-2_16
Unlock the Code for the Diagnosis and Treatment of Alzheimer’s Disease
(2024) · Journal of Neurology and Experimental Neuroscience · doi:10.17756/jnen.2024-117
Nguyen, Q.-T., & Duong‐Trung, N. (2025) · Lecture notes in computer science · doi:10.1007/978-981-96-8197-6_16
Proteomics for Novel Biomarker and Drug Target Discovery in Alzheimer Disease
Zhu, H., Cai, M., Chen, D., Sha, J., Du, L., Chen, Y., Liu, S., Zheng, Q., Wei, X., & Bai, B. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_12
Netrin‐1: Dual Roles in Neuroinflammation and Neurodegenerative Disease Dynamics
Farahani, H., Ganji, A., Mosayebi, G., Monfared, M. E., & Ghazavi, A. (2025) · International Journal of Inflammation · doi:10.1155/ijin/8670048
He, C., Zhan, M., Hu, X., Li, Y., Sun, L., Li, R., Chen, Z., & Du, Y. (2025) · Guidelines and Standards of Chinese Medicine · doi:10.1097/gscm.0000000000000068
O’Donald, F., Calia, C., & Parra, M. A. (2025) · Journal of Aging Research · doi:10.1155/jare/2610700
Stolpe, R., & Morel, Y. (2025) · Proceedings of the ... American Control Conference/Proceedings of the American Control Conference · doi:10.23919/acc63710.2025.11107985
Curing Alzheimer’s disease: Magic bullet or magic shotgun blast?
Weaver, D. F. (2025) · The Conversation · doi:10.64628/aam.d7cgqw5un
Lin, K., Yang, J., Li, H., Zhong, S., Zeng, X., Hu, W., Cheng, L., & Xu, S. (2025) · Research Square · doi:10.21203/rs.3.rs-7280838/v1
Clinical profiles and diagnostic trends in Alzheimer's disease: A retrospective observational study
Sakhri, F. Z., Sakhri, A., Daci, F., Chine, M. E., & Lakhdari, N. (2025) · Romanian Journal of Neurology · doi:10.37897/rjn.2025.3.3
Amyloid-β alters medial prefrontal cortex encoding of temporal order task
Lim, I. E., Vats, A., Vaughn, T., Choi, K., Adeyelu, T. T., & Ogundele, O. M. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251376293
Nanotechnology in Neuroscience Transforming Alzheimer's Therapy
Gudla, S. S., Vadaga, A. K., Bhumireddy, S. K. A., Kusuma Kumari, R., & Sharma, K. (2025) · doi:10.70593/978-93-7185-149-7_2
Sherman, E., Qiu, K., Roberts, R., Shichman, L., Li, S., Sun, H., Ide, L., Tucker, A., Lee, S., Gniadzik, W., et al. (2025) · SSRN Electronic Journal · doi:10.1101/2025.10.17.683162 · Cited by 1
El-Sofany, H. F., El-Sofany, A. E. H., Ahmed, A. M., Shanawaz Ahmed, J., & Bouallègue, B. (2025) · Mitteilungen Klosterneuburg · doi:10.61586/cywjg
takaliuang, D. S., Muljadi, R., Sutanto, R., & Situmeang, R. (2025) · Research Square · doi:10.21203/rs.3.rs-7953365/v1
Zou, J., Liao, R., Zhang, W., & Kuang, Z. (2025) · Brain Sciences · doi:10.3390/brainsci15101076
Gandhi, S., Goyal, S., Dixit, N., Patel, S., & Modi, P. (2025) · Chemical Papers · doi:10.1007/s11696-025-04442-5 · Cited by 1
Identification of ordinal relations and alternative suborders within high-dimensional molecular data
Stolnicu, A., Bellmann, P., Kestler, A. M. R., & Kestler, H. A. (2025) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2025.1665892
Cognitive Task Virtualization for Alzheimer's Diagnosis Using Realistic VR Simulation
Tjandra, C. N., Mubin, S. A., Djemal, K., & Feiz, A. A. (2025) · International Conference on Image Processing Theory, Tools and Applications (IPTA) · doi:10.1109/ipta66025.2025.11222054
Metadata
- Authors
- Tahami Monfared, A. A., Byrnes, M. J., White, L. A., & Zhang, Q.
- Affiliations
- Eisai (United States) (US)
- Venue
- Neurology and Therapy
- Published
- 2022-03-14
- Volume
- 11
- Issue
- 2
- Pages
- 553-569
- ISSN
- 2193-6536 (ISSN-L)
- 2193-8253
- PMC
- PMC9095793
- OpenAlex
- W4221041873
- Cited by
- 629
- References
- 74
- Citations by year
- 2026: 161 · 2025: 208 · 2024: 161 · 2023: 80 · 2022: 19
- FWCI
- 20.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neurology and Therapy (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Eisai
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- Alzheimer's disease, clinical progression, mild cognitive impairment, amyloid-beta deposition, neurodegeneration, preclinical Alzheimer's disease, disease risk factors, APOE ε4, white matter hyperintensities, entorhinal cortex atrophy, cerebrospinal fluid biomarkers, tau protein, neurogranin, dementia mortality, underdiagnosis, disease-modifying therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
